Cargando…
Tumor RNA-transfected dendritic cells and combined therapy with low dose 5-FU induce regression of murine colon cancer
Autores principales: | de Camargo, Marcela R, Gorgulho, Carolina M, Rodrigues, Cecília P, Frederico, Juliana CL, Zambuzi, Fabiana A, Galvão, Victoria E, Penitenti, Marcimara, Kaneno, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624119/ http://dx.doi.org/10.1186/1753-6561-7-S2-P45 |
Ejemplares similares
-
Optimization of Gene Transfection in Murine Myeloma Cell Lines using Different Transfection Reagents
por: Shabani, Mahdi, et al.
Publicado: (2010) -
In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes
por: Pappalardo, Juan Sebastián, et al.
Publicado: (2014) -
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
por: Kaneno, Ramon, et al.
Publicado: (2009) -
Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
por: Liszbinski, Raquel B., et al.
Publicado: (2020) -
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)